Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

NCT00381615 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
147
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Vaccines